Assyro AI
FDA 483 Database

FDA Form 483s Issued in 2022

Every published Form FDA 483 issued in 2022, drawn from the FDA OII FOIA Electronic Reading Room. Drill into any month, or open a record to see the firm, FEI number, establishment type, and location.

102

Published 483s in 2022

12

Months with records

Browse 2022 by month

Most recent Form 483s in 2022

Showing 25 of 102 — open a month above for the full list.

Revance Therapeutics, Inc.FDA
FEI
3007772056
Issued
Jul 15, 2022
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
United States
Biocon Sdn. Bhd.FDA
FEI
3011248248
Issued
Aug 30, 2022
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
Malaysia
Bushu Pharmaceuticals Ltd.FDA
FEI
3005709762
Issued
Dec 2, 2022
Establishment
Drug Manufacturer
Location
Japan
Vetter Pharma-Fertigung GmbH & Co. KGFDA
FEI
3005987757
Issued
Aug 26, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
Germany
Meiji Seika Pharma Co., Ltd.FDA
FEI
3008927877
Issued
Sep 2, 2022
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
Japan
Kyowa Hakko Bio Co., Ltd.FDA
FEI
3007807424
Issued
Apr 15, 2022
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
Japan
Chunghwa Chemical Synthesis & Biotech Co., Ltd.FDA
FEI
3002806677
Issued
Nov 18, 2022
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
Taiwan
Fuji Yakuhin Co., Ltd.FDA
FEI
3008538640
Issued
Nov 25, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
Japan
Zhejiang Tianyu Pharmaceutical Co. Ltd.FDA
FEI
3010972581
Issued
Mar 4, 2022
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
China
Laboratorios Farmaceuticos Rovi S. A.FDA
FEI
3010705046
Issued
Jun 27, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
Spain
Samsung BiologicsFDA
FEI
3010479596
Issued
Jun 9, 2022
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
Republic of Korea
Catalent Indiana LLCFDA
FEI
3005949964
Issued
Sep 1, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
United States
SentaraFDA
FEI
3011627411
Issued
Dec 16, 2022
Establishment
Producer of Sterile Drug Products
Location
Virginia, United States
MSLS LLC dba The Medicine ShoppeFDA
FEI
3012814943
Issued
Sep 28, 2022
Establishment
Producer of Non Sterile Drug Products
Location
Missouri, United States
iRhythm TechnologiesFDA
FEI
3021769057
Issued
Aug 12, 2022
Establishment
Medical Device Manufacturer
Location
California, United States
Nephron PharmaceuticalsFDA
FEI
3010247115
Issued
Dec 2, 2022
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Kentucky, United States
Eli Lilly and CompanyFDA
FEI
1819470
Issued
Oct 21, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
United States
QuVa Pharma, Inc.FDA
FEI
3012053582
Issued
Aug 18, 2022
Establishment
Outsourcing Facility
Location
Texas, United States
CareFirst Specialty Pharmacy LLCFDA
FEI
3012258924
Issued
Nov 30, 2022
Establishment
Producer of Non Sterile Drug Products
Location
New Jersey, United States
Barclay, Luke, & Pillai Specialty Pharmacy, PLLCFDA
FEI
3011888866
Issued
Dec 9, 2022
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Nevada, United States
Amneal Pharmaceuticals Private Ltd.FDA
FEI
3010254278
Issued
Dec 23, 2022
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Northern VA Compounders PLLCFDA
FEI
3012590153
Issued
Dec 9, 2022
Establishment
Producer of Non Sterile Drug Products
Location
Virginia, United States
RC Outsourcing LLCFDA
FEI
3011967886
Issued
Sep 23, 2022
Establishment
Outsourcing Facility
Location
Ohio, United States
Wells Pharma of Houston LLCFDA
FEI
3016710931
Issued
Dec 14, 2022
Establishment
Outsourcing Facility
Location
Texas, United States
PQ Pharmacy LLCFDA
FEI
3017374013
Issued
Oct 27, 2022
Establishment
Outsourcing Facility
Location
Florida, United States

Other years

Back to the FDA 483 Database